The DOI matches its Crossref record; 445 of the 445 references it cites were found in a registry or an index.
Tissue invasion and metastasis: Molecular, biological and clinical perspectives
Open accessAbstract
Cancer is a key health issue across the world, causing substantial patient morbidity and mortality. Patient prognosis is tightly linked with metastatic dissemination of the disease to distant sites, with metastatic diseases accounting for a vast percentage of cancer patient mortality. While advances in this area have been made, the process of cancer metastasis and the factors governing cancer spread and establishment at secondary locations is still poorly understood. The current article summarizes recent progress in this area of research, both in the understanding of the underlying biological processes and in the therapeutic strategies for the management of metastasis. This review lists the disruption of E-cadherin and tight junctions, key signaling pathways, including urokinase type plasminogen activator (uPA), phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene (PI3K/AKT), focal adhesion kinase (FAK), β-catenin/zinc finger E-box binding homeobox 1 (ZEB-1) and transforming growth factor beta (TGF-β), together with inactivation of activator protein-1 (AP-1) and suppression of matrix metalloproteinase-9 (MMP-9) activity as key targets and the use of phytochemicals, or natural products, such as those from Agaricus blazei, Albatrellus confluens, Cordyceps militaris, Ganoderma lucidum, Poria cocos and Silybum marianum, together with diet derived fatty acids gamma linolenic acid (GLA) and eicosapentanoic acid (EPA) and inhibitory compounds as useful approaches to target tissue invasion and metastasis as well as other hallmark areas of cancer. Together, these strategies could represent new, inexpensive, low toxicity strategies to aid in the management of cancer metastasis as well as having holistic effects against other cancer hallmarks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Akiyama, M., Hideshima, T., Hayashi, T., Tai, Y., Mitsiades, C. S., Mitsiades, N., Chauhan, D., Richardson, P. G. G., Munshi, N. C., & Anderson, K. C. (2003) · PubMed · Cited by 212
RetractedEbrahimnezhad, Z., Zarghami, N., Keyhani, M., Amirsaadat, S., Rahmati, M., Mohammad Taheri, Z., & Nejati‐Koshki, K. (2013) · Europe PMC (PubMed Central) · doi:10.5681/bi.2013.005 · Cited by 75
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Hynes (2002) · doi:10.1016/s0092-8674(02)00971-6 · Cited by 8,606
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
A Perspective on Cancer Cell Metastasis
Chaffer, C. L., & Weinberg, R. A. (2011) · Science · doi:10.1126/science.1203543 · Cited by 4,807
Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma
Morton, D. L. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420040034005 · Cited by 4,371
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H. M., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,051
Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,012
Natural products: A continuing source of novel drug leads
Cragg, G. M., & Newman, D. J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.008 · Cited by 2,906
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Metastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2622 · Cited by 2,649
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
CD44 is the principal cell surface receptor for hyaluronate
Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., & Seed, B. (1990) · Cell · doi:10.1016/0092-8674(90)90694-a · Cited by 2,438
CD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,386
Phenotypic characterization of human colorectal cancer stem cells
Dalerba, P., Dylla, S. J., Park, I.-K., Liu, R., Wang, X., Cho, R. W., Hoey, T., Gurney, A., Huang, E. H., Simeone, D. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703478104 · Cited by 2,184
Prince, M. E., Sivanandan, R., Kaczorowski, A., Wolf, G. T., Kaplan, M. J., Dalerba, P., Weissman, I. L., Clarke, M. F., & Ailles, L. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610117104 · Cited by 2,164
Self-citationNoninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Fizazi, K., Carducci, M., Smith, M., Damião, R., Brown, J., Karsh, L., Milecki, P., Shore, N., Rader, M., Wang, H., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62344-6 · Cited by 1,971
SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
Feng, X.-H., & Derynck, R. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.022404.142018 · Cited by 1,869
Molecular requirements for epithelial–mesenchymal transition during tumor progression
Huber, M. A., Kraut, N., & Beug, H. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.08.001 · Cited by 1,821
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,654
Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7101 · Cited by 1,597
Springer Science and Business Media
Montenarie, W. (2004) · The Library of Electronic Cyprus Thematic Organized Collections (LYKYTHOS) (University of Cyprus) · Cited by 1,402
Migrating cancer stem cells — an integrated concept of malignant tumour progression
Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., & Kirchner, T. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1694 · Cited by 1,352
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Ma, L., Young, J., Prabhala, H., Pan, E., Mestdagh, P., Muth, D., Teruya-Feldstein, J., Reinhardt, F., Onder, T. T., Valastyan, S., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2024 · Cited by 1,336
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
Cavallaro, U., & Christofori, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1276 · Cited by 1,311
Cancer to bone: a fatal attraction
Weilbaecher, K. N., Guise, T. A., & McCauley, L. K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3055 · Cited by 1,285
Henry, D. H., Costa, L., Goldwasser, F., Hirsh, V., Hungria, V., Prausova, J., Scagliotti, G. V., Sleeboom, H., Spencer, A., Vadhan-Raj, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.3304 · Cited by 1,263
Vincent, J., Mignot, G., Chalmin, F., Ladoire, S., Bruchard, M., Chevriaux, A., Martin, F., Apetoh, L., Rébé, C., & Ghiringhelli, F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3690 · Cited by 1,245
Sadeghi, B., Arvieux, C., Glehen, O., Beaujard, A. C., Rivoire, M., Baulieux, J., Fontaumard, E., Brachet, A., Caillot, J. L., Faure, J. L., et al. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000115)88:2<358::aid-cncr16>3.0.co;2-o · Cited by 1,200
Charafe-Jauffret, E., Ginestier, C., Iovino, F., Wicinski, J., Cervera, N., Finetti, P., Hur, M.-H., Diebel, M. E., Monville, F., Dutcher, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2741 · Cited by 1,173
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
Talmadge, J. E., & Fidler, I. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1040 · Cited by 1,169
Itoh, M., Furuse, M., Morita, K., Kubota, K., Saitou, M., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.6.1351 · Cited by 1,151
Denosumab in men receiving androgen-deprivation therapy for prostate cancer
Smith, M. R., Egerdie, B., Toriz, N. H., Feldman, R., Tammela, T. L. J., Saad, F., Heracek, J., Szwedowski, M., Ke, C., Kupic, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809003 · Cited by 1,140
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Zöller, M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3023 · Cited by 1,112
The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.
Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordán, J., Bellacosa, A., Tsichlis, P. N., & Hay, N. (1997) · Genes & Development · doi:10.1101/gad.11.6.701 · Cited by 1,074
Heinrich, M. C., Griffith, D. J., Druker, B. J., Wait, C. L., Ott, K. A., & Zigler, A. J. (2000) · Blood · doi:10.1182/blood.v96.3.925 · Cited by 1,071
Signaling Properties of Hyaluronan Receptors
Turley, E. A., Noble, P. W., & Bourguignon, L. Y. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100038200 · Cited by 1,041
Fasano, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2008 · Cited by 1,003
Merlos-Suárez, A., Barriga, F. M., Jung, P., Iglesias, M., Céspedes, M. V., Rossell, D., Sevillano, M., Hernando-Momblona, X., da Silva-Diz, V., Muñoz, P., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.02.020 · Cited by 934
Paxillin and focal adhesion signalling
Turner, C. E. (2000) · Nature Cell Biology · doi:10.1038/35046659 · Cited by 839
Structure and function of claudins
Krause, G., Winkler, L., Mueller, S. L., Haseloff, R. F., Piontek, J., & Blasig, I. E. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.10.018 · Cited by 829
TGF- β signaling in cancer – a double-edged sword
Akhurst, R. J., & Derynck, R. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02130-4 · Cited by 756
The two faces of transforming growth factor β in carcinogenesis
Roberts, A. B., & Wakefield, L. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633291100 · Cited by 747
Shiozawa, Y., Pedersen, E. A., Havens, A. M., Jung, Y., Mishra, A., Joseph, J., Kim, J. K., Patel, L. R., Ying, C., Ziegler, A. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43414 · Cited by 718
Shrimali, R. K., Yu, Z., Theoret, M. R., Chinnasamy, D., Restifo, N. P., & Rosenberg, S. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0153 · Cited by 677
Tan, W., Zhang, W., Strasner, A., Grivennikov, S., Cheng, J. Q., Hoffman, R. M., & Karin, M. (2011) · Nature · doi:10.1038/nature09707 · Cited by 647
The Collagenolytic Activity of Cathepsin K Is Unique among Mammalian Proteinases
Garnero, P., Borel, O., Byrjalsen, I., Ferreras, M., Drake, F. H., McQueney, M. S., Foged, N. T., Delmas, P. D., & Delaissé, J.-M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32347 · Cited by 644
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
Rubin, J. B., Kung, A. L., Klein, R. S., Chan, J. A., Sun, Y., Schmidt, K., Kieran, M. W., Luster, A. D., & Segal, R. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235846100 · Cited by 615
Axis of evil: molecular mechanisms of cancer metastasis
Bogenrieder, T., & Herlyn, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206757 · Cited by 593
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Bhola, N. E., Balko, J. M., Dugger, T. C., Kuba, M. G., Sánchez, V., Sanders, M., Stanford, J., Cook, R. S., & Arteaga, C. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65416 · Cited by 590
The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity
Park, S., Jiang, Z., Mortenson, E. D., Deng, L., Radkevich-Brown, O., Yang, X., Sattar, H., Wang, Y., Brown, N. K., Greene, M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.014 · Cited by 577
Self-citationCorrelation of Snail expression with histological grade and lymph node status in breast carcinomas
Blanco, M. J., Moreno-Bueno, G., Sarrio, D., Locascio, A., Cano, A., Palacios, J., & Nieto, M. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205416 · Cited by 576
Rosivatz, E., Becker, I., Specht, K., Fricke, E., Luber, B., Busch, R., Höfler, H., & Becker, K.-F. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64464-1 · Cited by 572
Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer
Dhawan, P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24543 · Cited by 566
Self-citationDevelopment of TGF-β signalling inhibitors for cancer therapy
Yingling, J. M., Blanchard, K. L., & Sawyer, J. S. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1580 · Cited by 549
Gottardi, C. J., Wong, E., & Gumbiner, B. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.1049 · Cited by 544
A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
Pang, R., Law, W. L., Chu, A. C. Y., Poon, J. T., Lam, C. S. C., Chow, A. K. M., Ng, L., Cheung, L. W. H., Lan, X. R., Lan, H. Y., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.001 · Cited by 540
Predicted expansion of the claudin multigene family
Mineta, K., Yamamoto, Y., Yamazaki, Y., Tanaka, H., Tada, Y., Saito, K., Tamura, A., Igarashi, M., Endo, T., Takeuchi, K., et al. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.01.028 · Cited by 531
Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer
de Boer, M., van Deurzen, C. H. M., van Dijck, J. A. A. M., Borm, G. F., van Diest, P. J., Adang, E. M. M., Nortier, J. W. R., Rutgers, E. J. T., Seynaeve, C., Menke-Pluymers, M. B. E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904832 · Cited by 524
Transforming growth factor-β in cancer and metastasis
Jakowlew, S. B. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9006-2 · Cited by 517
Gilmore, A. P., & Romer, L. H. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.8.1209 · Cited by 513
Hough, C. D., Sherman‐Baust, C. A., Pizer, E. S., Montz, F. J., Im, D. D., Rosenshein, N. B., Cho, K. R., Riggins, G. J., & Morin, P. J. (2000) · PubMed · Cited by 502
Medici, D., Hay, E. D., & Olsen, B. R. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-05-0506 · Cited by 497
Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells
Prasad, S., Mingrino, R., Kaukinen, K., Hayes, K. L., Powell, R. M., MacDonald, T. T., & Collins, J. E. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700316 · Cited by 490
Martin, T. A., Goyal, A., Watkins, G., & Jiang, W. G. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.04.010 · Cited by 486
Self-citationSchittenhelm, M. M., Shiraga, S., Schroeder, A., Corbin, A. S., Griffith, D., Lee, F. Y., Bokemeyer, C., Deininger, M. W. N., Druker, B. J., & Heinrich, M. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2050 · Cited by 468
Broad targeting of angiogenesis for cancer prevention and therapy
Wang, Z., Dabrosin, C., Yin, X., Fuster, M. M., Arreola, A., Rathmell, W. K., Generali, D., Nagaraju, G. P., El-Rayes, B., Ribatti, D., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.01.001 · Cited by 464
Self-citationE-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1
St. Croix, B., Sheehan, C., Rak, J. W., Flørenes, V. A., Slingerland, J. M., & Kerbel, R. S. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.2.557 · Cited by 452
Kominsky, S. L., Argani, P., Korz, D., Evron, E., Raman, V., Garrett, E., Rein, A., Sauter, G., Kallioniemi, O.-P., & Sukumar, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206199 · Cited by 448
Clay, M. R., Tabor, M., Owen, J. H., Carey, T. E., Bradford, C. R., Wolf, G. T., Wicha, M. S., & Prince, M. E. (2010) · Head & Neck · doi:10.1002/hed.21315 · Cited by 447
Self-citationSmith, D. C., Smith, M. R., Sweeney, C., Elfiky, A. A., Logothetis, C., Corn, P. G., Vogelzang, N. J., Small, E. J., Harzstark, A. L., Gordon, M. S., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.0494 · Cited by 446
Claudin-11/OSP-based Tight Junctions of Myelin Sheaths in Brain and Sertoli Cells in Testis
Morita, K., Sasaki, H., Fujimoto, K., Furuse, M., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.3.579 · Cited by 442
Lu, K. H., Patterson, A. P., Wang, L., Marquez, R. T., Atkinson, E. N., Baggerly, K. A., Ramoth, L. R., Rosen, D. G., Liu, J., Hellstrom, I., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0409 · Cited by 440
Bogdahn, U., Hau, P., Stockhammer, G., Venkataramana, N. K., Mahapatra, A. K., Suri, A., Balasubramaniam, A., Nair, S., Oliushine, V., Parfenov, V., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq142 · Cited by 433
Yaccoby, S., Ling, W., Zhan, F., Walker, R., Barlogie, B., & Shaughnessy, J. D. (2007) · Blood · doi:10.1182/blood-2006-09-047712 · Cited by 433
Uhl, M., Aulwurm, S., Wischhusen, J., Weiler, M., Ma, J. Y., Almirez, R., Mangadu, R., Liu, Y.-W., Platten, M., Herrlinger, U., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1013 · Cited by 414
Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells
Loser, K., Mehling, A., Loeser, S., Apelt, J., Kuhn, A., Grabbe, S., Schwarz, T., Penninger, J. M., & Beissert, S. (2006) · Nature Medicine · doi:10.1038/nm1518 · Cited by 402
Wu, X., Hepner, K., Castelino-Prabhu, S., Do, D., Kaye, M. B., Yuan, X.-J., Wood, J., Ross, C., Sawyers, C. L., & Whang, Y. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4233 · Cited by 400
Zaidi, S. K., Sullivan, A. J., Medina, R., Ito, Y., van Wijnen, A. J., Stein, J. L., Lian, J. B., & Stein, G. S. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600073 · Cited by 398
Agarwal, R., D'Souza, T., & Morin, P. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1036 · Cited by 374
Targeting of TAK1 in inflammatory disorders and cancer
Sakurai, H. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.06.007 · Cited by 373
Epithelial–mesenchymal transition and tumour invasion
Guarino, M. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.07.011 · Cited by 368
Devine, S. M., Flomenberg, N., Vesole, D. H., Liesveld, J., Weisdorf, D., Badel, K., Calandra, G., & DiPersio, J. F. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.131 · Cited by 368
Direct Evidence for Epithelial-Mesenchymal Transitions in Breast Cancer
Trimboli, A. J., Fukino, K., de Bruin, A., Wei, G., Shen, L., Tanner, S. M., Creasap, N., Rosol, T. J., Robinson, M. L., Eng, C., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2148 · Cited by 368
Gottardi, C. J., Arpin, M., Fanning, A. S., & Louvard, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10779 · Cited by 367
NF-κB–mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia
He, W. A., Berardi, E., Cardillo, V. M., Acharyya, S., Aulino, P., Thomas-Ahner, J., Wang, J., Bloomston, M., Muscarella, P., Nau, P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68523 · Cited by 357
Molecular networks that regulate cancer metastasis
Spano, D., Heck, C., De Antonellis, P., Christofori, G., & Zollo, M. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.03.006 · Cited by 357
Self-citationStockinger, A., Eger, A., Wolf, J., Beug, H., & Foisner, R. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200104036 · Cited by 335
Rangel, L. B. A., Agarwal, R., D’Souza, T., Pizer, E. S., Alò, P., Lancaster, W. D., Grégoire, L., Schwartz, D. R., Cho, K. R., & Morin, P. J. (2003) · PubMed · Cited by 335
Spencer, G. J., Utting, J. C., Etheridge, S. L., Arnett, T. R., & Genever, P. G. (2006) · Journal of Cell Science · doi:10.1242/jcs.02883 · Cited by 334
Melisi, D., Ishiyama, S., Sclabas, G. M., Fleming, J. B., Xia, Q., Tortora, G., Abbruzzese, J. L., & Chiao, P. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0337 · Cited by 323
Iclozan, C., Antonia, S., Chiappori, A., Chen, D.-T., & Gabrilovich, D. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1396-8 · Cited by 317
Miwa, N., Furuse, M., Tsukita, S., Niikawa, N., Nakamura, Y., & Furukawa, Y. (2001) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504001108747477 · Cited by 298
Distinct types of tumor-initiating cells form human colon cancer tumors and metastases
Dieter, S. M., Ball, C. R., Hoffmann, C. M., Nowrouzi, A., Herbst, F., Zavidij, O., Abel, U., Arens, A., Weichert, W., Brand, K., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.08.010 · Cited by 297
Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer.
Michl, P., Barth, C., Buchholz, M., Lerch, M. M., Rolke, M., Holzmann, K., Menke, A., Fensterer, H., Giehl, K., Löhr, M. J., et al. (2003) · PubMed · Cited by 295
Martínez-Estrada, O. M., Cullerés, A., Soriano, F. X., Peinado, H., Bolós, V., Martínez, F. O., Reina, M., Cano, A., Fabre, M., & Vilaró, S. (2006) · Biochemical Journal · doi:10.1042/bj20050591 · Cited by 295
Hyaluronan in human malignancies
Sironen, R. K., Tammi, M., Tammi, R., Auvinen, P. K., Anttila, M., & Kosma, V.-M. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.11.017 · Cited by 294
Veltman, J. D., Lambers, M. E., van Nimwegen, M., Hendriks, R. W., Hoogsteden, H. C., Aerts, J. G., & Hegmans, J. P. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-464 · Cited by 291
Halder, S. K., Beauchamp, R. D., & Datta, P. K. (2005) · Neoplasia · doi:10.1593/neo.04640 · Cited by 288
Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity
Loo, D., Alderson, R. F., Chen, F. Z., Huang, L., Zhang, W., Gorlatov, S., Burke, S., Ciccarone, V., Li, H., Yang, Y., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0715 · Cited by 284
Schley, P. D., Brindley, D. N., & Field, C. J. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.3.548 · Cited by 281
Li, J., Yang, B., Zhou, Q., Wu, Y., Shang, D., Guo, Y., Song, Z., Zheng, Q., & Xiong, J. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt063 · Cited by 280
Tang, W., Liu, J.-W., Zhao, W.-M., Wei, D.-Z., & Zhong, J.-J. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.09.001 · Cited by 275
Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins
Yamauchi, K., Rai, T., Kobayashi, K., Sohara, E., Suzuki, T., Itoh, T., Suda, S., Hayama, A., Sasaki, S., & Uchida, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306924101 · Cited by 271
Epithelial-Mesenchymal Transition in tumor microenvironment
Jing, Y., Han, Z., Zhang, S., Liu, Y., & Wei, L. (2011) · Cell & Bioscience · doi:10.1186/2045-3701-1-29 · Cited by 270
DNA methylation in development and human disease
Gopalakrishnan, S., Van Emburgh, B. O., & Robertson, K. D. (2008) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2008.08.006 · Cited by 266
Chung, J. Y., Huang, C., Meng, X., Dong, Z., & Yang, C. S. (1999) · PubMed · Cited by 262
Targeting the transforming growth factor-β signaling pathway in human cancer
Nagaraj, N. S., & Datta, P. K. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903382609 · Cited by 262
Regulation of tumor angiogenesis by integrin-linked kinase (ILK)
Tan, C., Cruet-Hennequart, S., Troussard, A., Fazli, L., Costello, P., Sutton, K., Wheeler, J., Gleave, M., Sanghera, J., & Dedhar, S. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00281-2 · Cited by 260
Fransvea, E., Angelotti, U., Antonaci, S., & Giannelli, G. (2008) · Hepatology · doi:10.1002/hep.22201 · Cited by 253
MHC Class II Engagement by Its Ligand LAG-3 (CD223) Contributes to Melanoma Resistance to Apoptosis
Hemon, P., Jean-Louis, F., Ramgolam, K., Brignone, C., Viguier, M., Bachelez, H., Triebel, F., Charron, D., Aoudjit, F., Al-Daccak, R., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002050 · Cited by 252
Burgess, T., Coxon, A., Meyer, S., Sun, J., Rex, K., Tsuruda, T., Chen, Q., Ho, S.-Y., Li, L., Kaufman, S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3329 · Cited by 252
Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study
Resnick, M. B., Konkin, T., Routhier, J., Sabo, E., & Pricolo, V. E. (2005) · Modern Pathology · doi:10.1038/modpathol.3800301 · Cited by 250
Hepatocyte growth factor, its receptor, and their potential value in cancer therapies
Jiang, W. G., Martin, T. A., Parr, C., Davies, G., Matsumoto, K., & Nakamura, T. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.09.004 · Cited by 248
Self-citationPhytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis
Shu, L., Cheung, K.-L., Khor, T. O., Chen, C., & Kong, A.-N. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9239-y · Cited by 245
Liu, X.-H., Kirschenbaum, A., Yao, S., & Levine, A. C. (2005) · Endocrinology · doi:10.1210/en.2004-1167 · Cited by 240
Nacht, M., Ferguson, A. T., Zhang, W., Petroziello, J. M., Cook, B. P., Gao, Y. H., Maguire, S., Riley, D., Coppola, G., Landes, G. M., et al. (1999) · PubMed · Cited by 237
Morgan, T. M., Lange, P. H., Porter, M. P., Lin, D. W., Ellis, W. J., Gallaher, I. S., & Vessella, R. L. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1754 · Cited by 229
Miyamori, H., Takino, T., Kobayashi, Y., Tokai, H., Itoh, Y., Seiki, M., & Sato, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103083200 · Cited by 228
E-cadherin Regulates Anchorage-independent Growth and Survival in Oral Squamous Cell Carcinoma Cells
Kantak, S. S., & Kramer, R. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16953 · Cited by 227
Regulation and roles for claudin‐family tight junction proteins
Findley, M. K., & Koval, M. (2009) · IUBMB Life · doi:10.1002/iub.175 · Cited by 224
Integrin αvβ3 expression confers on tumor cells a greater propensity to metastasize to bone
Pecheur, I., Peyruchaud, O., Serre, C., Guglielmi, J., Voland, C., Bourre, F., Margue, C., Cohen‐Solal, M., Buffet, A., Kieffer, N., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0911fje · Cited by 223
TGF-β-RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases
Mohammad, K. S., Javelaud, D., Fournier, P. G. J., Niewolna, M., McKenna, C. R., Peng, X. H., Duong, V., Dunn, L. K., Mauviel, A., & Guise, T. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2651 · Cited by 221
Megaintestine in Claudin-15–Deficient Mice
Tamura, A., Kitano, Y., Hata, M., Katsuno, T., Moriwaki, K., Sasaki, H., Hayashi, H., Suzuki, Y., Noda, T., Furuse, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.040 · Cited by 220
D'Souza, T., Agarwal, R., & Morin, P. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502003200 · Cited by 220
Weng, C.-J., & Yen, G.-C. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9347-y · Cited by 219
Wnt and beyond Wnt: Multiple mechanisms control the transcriptional property of β-catenin
Jin, T., George Fantus, I., & Sun, J. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.04.014 · Cited by 215
Hau, P., Jachimczak, P., Schlingensiepen, R., Schulmeyer, F., Jauch, T., Steinbrecher, A., Brawanski, A., Proescholdt, M., Schlaier, J., Buchroithner, J., et al. (2007) · Oligonucleotides · doi:10.1089/oli.2006.0053 · Cited by 215
Persistent E-Cadherin Expression in Inflammatory Breast Cancer
Kleer, C. G., van Golen, K. L., Braun, T., & Merajver, S. D. (2001) · Modern Pathology · doi:10.1038/modpathol.3880334 · Cited by 214
Singh, A. B., & Harris, R. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308682200 · Cited by 210
Malignant Ascites: Clinical and Experimental Observations
GARRISON, R. N., KAELIN, L. D., HEUSER, L. S., & GALLOWAY, R. H. (1986) · Annals of Surgery · doi:10.1097/00000658-198606000-00009 · Cited by 208
A Cathepsin K Inhibitor Reduces Breast Cancer–Induced Osteolysis and Skeletal Tumor Burden
Le Gall, C., Bellahcène, A., Bonnelye, E., Gasser, J. A., Castronovo, V., Green, J., Zimmermann, J., & Clézardin, P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3940 · Cited by 204
Targeting tumor cell motility as a strategy against invasion and metastasis
Wells, A., Grahovac, J., Wheeler, S., Ma, B., & Lauffenburger, D. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.03.001 · Cited by 201
Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours
Soini, Y. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02127.x · Cited by 200
EphA2 Phosphorylates the Cytoplasmic Tail of Claudin-4 and Mediates Paracellular Permeability
Tanaka, M., Kamata, R., & Sakai, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503786200 · Cited by 195
Wnt/Snail Signaling Regulates Cytochrome c Oxidase and Glucose Metabolism
Lee, S. Y., Jeon, H. M., Ju, M. K., Kim, C. H., Yoon, G., Han, S. I., Park, H. G., & Kang, H. S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0006 · Cited by 195
Tumor microenvironment: a main actor in the metastasis process
Spano, D., & Zollo, M. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9457-5 · Cited by 194
Self-citationHjelmeland, M. D., Hjelmeland, A. B., Sathornsumetee, S., Reese, E. D., Herbstreith, M. H., Laping, N. J., Friedman, H. S., Bigner, D. D., Wang, X.-F., & Rich, J. N. (2004) · PubMed · Cited by 192
CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
Domanska, U. M., Timmer-Bosscha, H., Nagengast, W. B., Oude Munnink, T. H., Kruizinga, R. C., Ananias, H. J. K., Kliphuis, N. M., Huls, G., De Vries, E. G. E., de Jong, I. J., et al. (2012) · Neoplasia · doi:10.1593/neo.12324 · Cited by 191
Rosanò, L., Cianfrocca, R., Spinella, F., Di Castro, V., Nicotra, M. R., Lucidi, A., Ferrandina, G., Natali, P. G., & Bagnato, A. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2325 · Cited by 187
Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530
Chang, Y.-M., Bai, L., Liu, S., Yang, J. C., Kung, H.-J., & Evans, C. P. (2008) · Oncogene · doi:10.1038/onc.2008.250 · Cited by 185
Santini, D., Schiavon, G., Vincenzi, B., Gaeta, L., Pantano, F., Russo, A., Ortega, C., Porta, C., Galluzzo, S., Armento, G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019234 · Cited by 185
Self-citationHyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance
Toole, B. P., & Slomiany, M. G. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.04.002 · Cited by 182
Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLC
Heavey, S., O’Byrne, K. J., & Gately, K. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.08.006 · Cited by 178
Silibinin Inhibits Colorectal Cancer Growth by Inhibiting Tumor Cell Proliferation and Angiogenesis
Singh, R. P., Gu, M., & Agarwal, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6247 · Cited by 177
Hjelmeland, M. D., Hjelmeland, A. B., Sathornsumetee, S., Reese, E. D., Herbstreith, M. H., Laping, N. J., Friedman, H. S., Bigner, D. D., Wang, X.-F., & Rich, J. N. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.737.3.6 · Cited by 177
Mazzocca, A., Fransvea, E., Dituri, F., Lupo, L., Antonaci, S., & Giannelli, G. (2010) · Hepatology · doi:10.1002/hep.23285 · Cited by 176
Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function
Jean, C., Chen, X. L., Nam, J.-O., Tancioni, I., Uryu, S., Lawson, C., Ward, K. K., Walsh, C. T., Miller, N. L. G., Ghassemian, M., et al. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201307067 · Cited by 176
Claudin-1 Is a Metastasis Suppressor and Correlates with Clinical Outcome in Lung Adenocarcinoma
Chao, Y.-C., Pan, S.-H., Yang, S.-C., Yu, S.-L., Che, T.-F., Lin, C.-W., Tsai, M.-S., Chang, G.-C., Wu, C.-H., Wu, Y.-Y., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-456oc · Cited by 174
Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies
Xie, Y., Bagby, T. R., Cohen, M., & Forrest, M. L. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903085128 · Cited by 169
Usami, Y., Chiba, H., Nakayama, F., Ueda, J., Matsuda, Y., Sawada, N., Komori, T., Ito, A., & Yokozaki, H. (2006) · Human Pathology · doi:10.1016/j.humpath.2005.12.018 · Cited by 168
Ganapathy, V., Ge, R., Grazioli, A., Xie, W., Banach-Petrosky, W., Kang, Y., Lonning, S., McPherson, J., Yingling, J. M., Biswas, S., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-122 · Cited by 168
Inhibition of NF-κB Activity Decreases the VEGF mRNA Expression in MDA-MB-231 Breast Cancer Cells
Shibata, A., Nagaya, T., Imai, T., Funahashi, H., Nakao, A., & Seo, H. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1015872531675 · Cited by 167
Sakaguchi, T., Gu, X., Golden, H. M., Suh, E., Rhoads, D. B., & Reinecker, H.-C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110261200 · Cited by 167
Osteotropic cancers: From primary tumor to bone
Buijs, J. T., & van der Pluijm, G. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.05.044 · Cited by 167
Cordycepin Inhibits Protein Synthesis and Cell Adhesion through Effects on Signal Transduction
Wong, Y. Y., Moon, A., Duffin, R., Barthet-Barateig, A., Meijer, H. A., Clemens, M. J., & de Moor, C. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.071159 · Cited by 163
Cathepsin K mRNA and Protein Expression in Prostate Cancer Progression
Brubaker, K., Vessella, R., True, L., Thomas, R., & Corey, E. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.2.222 · Cited by 162
Lirdprapamongkol, K., Kramb, J.-P., Suthiphongchai, T., Surarit, R., Srisomsap, C., Dannhardt, G., & Svasti, J. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf803366f · Cited by 161
Singh, R. P., Raina, K., Sharma, G., & Agarwal, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1309 · Cited by 161
Reichert, M., Müller, T., & Hunziker, W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9492 · Cited by 159
Multitasking in Tumor Progression: Signaling Functions of Cell Adhesion Molecules
CAVALLARO, U., & CHRISTOFORI, G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.006 · Cited by 159
Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer
Serini, S., Piccioni, E., Merendino, N., & Calviello, G. (2009) · APOPTOSIS · doi:10.1007/s10495-008-0298-2 · Cited by 159
Transforming Growth Factor-Beta: Recent Advances on Its Role in Immune Tolerance
Mantel, P., & Schmidt‐Weber, C. B. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-869-0_21 · Cited by 158
Cunliffe, W. J., & Sugarbaker, P. H. (1989) · British journal of surgery · doi:10.1002/bjs.1800761030 · Cited by 156
Ge, R., Rajeev, V., Ray, P., Lattime, E. C., Rittling, S. R., Medicherla, S., Protter, A., Murphy, A., Chakravarty, J., Dugar, S., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0162 · Cited by 155
Mira, E., Lacalle, R. A., Buesa, J. M., de Buitrago, G. G., Jiménez-Baranda, S., Gómez‐Moutón, C., Martínez‐A, C., & Mañes, S. (2004) · Journal of Cell Science · doi:10.1242/jcs.01035 · Cited by 155
Bausch, D., Pausch, T. M., Krauß, T., Hopt, U. T., Fernández‐del‐Castillo, C., Warshaw, A. L., Thayer, S. P., & Keck, T. (2011) · Angiogenesis · doi:10.1007/s10456-011-9207-3 · Cited by 154
Src Family Kinase Activity Is Up-Regulated in Hormone-Refractory Prostate Cancer
Tatarov, O., Mitchell, T. J., Seywright, M. M., Leung, H. Y., Brunton, V. G., & Edwards, J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1857 · Cited by 153
Jensen, A. B., Wynne, C. J., Ramírez, G., He, W., Song, Y., Berd, Y., Wang, H., Mehta, A., & Lombardi, A. (2010) · Clinical Breast Cancer · doi:10.3816/cbc.2010.n.059 · Cited by 151
Jiang, J., Grieb, B. C., Thyagarajan‐Sahu, A., & Slíva, D. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.21.5.577 · Cited by 151
Creighton, C. J., Gibbons, D. L., & Kurie, J. M. (2013) · Cancer Management and Research · doi:10.2147/cmar.s35171 · Cited by 150
Cao, Q., & Lin, Z. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.07.017 · Cited by 150
Weng, C., Chau, C., Hsieh, Y., Yang, S., & Yen, G. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm261 · Cited by 150
Kim, K. J., Wang, L., Su, Y.-C., Gillespie, G. Y., Salhotra, A., Lal, B., & Laterra, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1793 · Cited by 150
Hawkins, R. A., Sangster, K., & Arends, M. J. (1998) · The Journal of Pathology · Cited by 148
Collares‐Buzato, C. B., Jepson, M. A., Simmons, N. L., & Hirst, B. H. (1998) · European Journal of Cell Biology · doi:10.1016/s0171-9335(98)80020-4 · Cited by 147
Escaffit, F., Boudreau, F., & Beaulieu, J. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20189 · Cited by 146
E-cadherin and its associated protein catenins, cancer invasion and metastasis
Jiang, W. G. (1996) · British journal of surgery · doi:10.1002/bjs.1800830404 · Cited by 144
Self-citationWu, G., Lu, J., Guo, J.-J., Li, Y., Tan, W., Dang, Y., Zhong, Z., Xu, Z., Chen, X., & Wang, Y. (2011) · Fitoterapia · doi:10.1016/j.fitote.2011.12.004 · Cited by 143
Junctions gone bad: Claudins and loss of the barrier in cancer
Turksen, K., & Troy, T. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.04.001 · Cited by 142
Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide.
Cao, Q., & Lin, Z. (2004) · PubMed · Cited by 140
Novel selective ligands for free fatty acid receptors GPR120 and GPR40
Hara, T., Hirasawa, A., Sun, Q. L., Sadakane, K., Itsubo, C., Iga, T., Adachi, T., Koshimizu, T., Hashimoto, T., Asakawa, Y., et al. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-009-0425-9 · Cited by 140
Fransvea, E., Mazzocca, A., Antonaci, S., & Giannelli, G. (2008) · Hepatology · doi:10.1002/hep.22731 · Cited by 140
Role of tight junctions in cell proliferation and cancer
González‐Mariscal, L., Lechuga, S., & Garay, E. (2007) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2007.01.001 · Cited by 139
Sànchez‐Tilló, E., Fanlo, L., Siles, L., Montes‐Moreno, S., Moros, A., Chiva‐Blanch, G., Estruch, R., Martínez, A., Colomer, D., Győrffy, B., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.123 · Cited by 139
Cited by
Abed, J., Emgård, J. E. M., Zamir, G., Faroja, M., Almogy, G., Grenov, A., Sol, A., Naor, R., Pikarsky, E., Atlan, K. A., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.07.006 · Cited by 888
Bisphenol A (BPA) and cell signaling pathways
Murata, M., & Kang, J.-H. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.12.002 · Cited by 361
Recent advances in magnetic fluid hyperthermia for cancer therapy
Das, P., Colombo, M., & Prosperi, D. (2019) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2018.10.051 · Cited by 329
Rynkeviciene, R., Simiene, J., Strainiene, E., Stankevicius, V., Usinskiene, J., Miseikyte Kaubriene, E., Meskinyte, I., Cicenas, J., & Suziedelis, K. (2018) · Cancers · doi:10.3390/cancers11010017 · Cited by 136
Stroma in normal and cancer wound healing
Huet, E., Jaroz, C., Nguyen, H. Q., Belkacemi, Y., de la Taille, A., Stavrinides, V., & Whitaker, H. (2019) · The FEBS Journal · doi:10.1111/febs.14842 · Cited by 42
Metadata
- Authors
- Jiang, W. G., Sanders, A. J., Katoh, M., Ungefroren, H., Gieseler, F., Prince, M., Thompson, S. K., Zollo, M., Spano, D., Dhawan, P., Sliva, D., Subbarayan, P. R., Sarkar, M., Honoki, K., Fujii, H., Georgakilas, A. G., Amedei, A., Niccolai, E., Amin, A., Ashraf, S. S., Ye, L., Helferich, W. G., Yang, X., Boosani, C. S., Guha, G., Ciriolo, M. R., Aquilano, K., Chen, S., Azmi, A. S., Keith, W. N., Bilsland, A., Bhakta, D., Halicka, D., Nowsheen, S., Pantano, F., & Santini, D.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 35
- Pages
- S244-S275
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2008514427
- Cited by
- 515
- References
- 445
- FWCI
- 18.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.